CD4 and gastric cancer: Particularly, the CD4+CD25+ T cells, marked by upregulated FOXP3 mRNA expression and intracellular CTLA-4 molecules, are related to poorer prognosis and survival rates in patients with GC and EC (Kono et al., 2006).